Fujirebio's Lumipulse® G pTau217/β-Amyloid 1-42 Plasma Ratio test has the potential to shorten the Alzheimer's disease ...
Biosensing plays a fundamental role in the latest technology that sheds light on how G protein-coupled receptors are activated by synthetic cannabinoid receptor agonists.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback